For adults and children age two and up, the standard Menveo dosage is a single 0.5-mL dose, injected into a muscle. Unlike many other vaccines, there are not separate versions of this product for adults and for children. An optional second dose, given two months after the first, can be given for children age two to five years of age.
Menveo contains no preservatives (including thimerosal) and does not contain aluminum or other adjuvants (an adjuvant is an ingredient that does not induce any immune response by itself but increases the immune response of other components of the vaccine).
Only one dose of this vaccine is recommended, and no booster doses are recommended at this time. As is typical with new or relatively new vaccines, it is possible that a booster dose of Menveo will someday be recommended. However, it is simply too early to know exactly how long Menveo will provide protection against bacterial meningitis and other invasive meningococcal diseases.
Menveo Dosing Schedule for Babies and Toddlers
For babies, four doses are required at 2, 4, 6, and 12 months of age. For babies and toddlers age seven months and older just starting the vaccine, two doses are required. The second dose should be given in the second year of life between the first and second birthdays and at least three months after the first dose.
Centers for Disease Control and Prevention (CDC). Vaccine information statement: meningococcal vaccines (01/28/08). CDC Web site. Available at: http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed February 23, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click